Abstract
Polymyalgia rheumatica (PMR) is considered to be a benign disease by some, while others think it is a more serious illness which required similar treatment to giant cell arteritis (GCA). The progress of 85 patients with PMR who presented to a district general hospital has been studied in an attempt to study this relationship. Thirty-eight patients had PMR alone, and 14 developed PMR and GCA within 1 month. Five patients presented with GCA and then developed PMR, and 28 patients developed symptoms of GCA after presenting with PMR (PMR leads to GCA). Arteritis and complications developed up to 9 years after the onset of PMR (mean 1 year). Twenty-two patients (26%) developed some cerebral or visual complication. Fifteen of these patients were in the PMR leads to GCA group. All 6 patients with permanent loss of vision were in this group. Seven patients developed complications while on corticosteroids. 97% of patients required corticosteroids for at least 1 year; 32% of patients still required 10 mg of prednisone or more after 1 year. PMR is not a benign disease.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Coomes E. N., Ellis R. M., Kay A. G. A prospective study of 102 patients with the polymyalgia rheumatica syndrome. Rheumatol Rehabil. 1976 Nov;15(4):270–279. doi: 10.1093/rheumatology/15.4.270. [DOI] [PubMed] [Google Scholar]
- Ettlinger R. E., Hunder G. G., Ward L. E. Polymyalgia rheumatica and giant cell arteritis. Annu Rev Med. 1978;29:15–22. doi: 10.1146/annurev.me.29.020178.000311. [DOI] [PubMed] [Google Scholar]
- Fauchald P., Rygvold O., Oystese B. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann Intern Med. 1972 Dec;77(6):845–852. doi: 10.7326/0003-4819-77-6-845. [DOI] [PubMed] [Google Scholar]
- HOLLENHORST R. W., BROWN J. R., WAGENER H. P., SHICK R. M. Neurologic aspects of temporal arteritis. Neurology. 1960 May;10:490–498. doi: 10.1212/wnl.10.5.490. [DOI] [PubMed] [Google Scholar]
- Hamilton C. R., Jr, Shelley W. M., Tumulty P. A. Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica. Medicine (Baltimore) 1971 Jan;50(1):1–27. [PubMed] [Google Scholar]
- Harrison M. J., Bevan A. T. Early symptoms of temporal arteritis. Lancet. 1967 Sep 23;2(7517):638–640. doi: 10.1016/s0140-6736(67)90684-8. [DOI] [PubMed] [Google Scholar]
- Healey L. A., Wilske K. R. Manifestations of giant cell arteritis. Med Clin North Am. 1977 Mar;61(2):261–270. doi: 10.1016/s0025-7125(16)31331-1. [DOI] [PubMed] [Google Scholar]
- Hunder G. G., Allen G. L. Giant cell arteritis: a review. Bull Rheum Dis. 1978;29(3-4):980–986. [PubMed] [Google Scholar]
- Huston K. A., Hunder G. G., Lie J. T., Kennedy R. H., Elveback L. R. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978 Feb;88(2):162–167. doi: 10.7326/0003-4819-88-2-162. [DOI] [PubMed] [Google Scholar]
- Klein R. G., Campbell R. J., Hunder G. G., Carney J. A. Skip lesions in temporal arteritis. Mayo Clin Proc. 1976 Aug;51(8):504–510. [PubMed] [Google Scholar]
- Malmvall B. E., Bengtsson B. A. Giant cell arteritis. Clinical features and involvement of different organs. Scand J Rheumatol. 1978;7(3):154–158. doi: 10.3109/03009747809095645. [DOI] [PubMed] [Google Scholar]
- Myles A. B. Polymyalgia rheumatica and giant cell arteritis: a seven-year survey. Rheumatol Rehabil. 1975 Nov;14(4):231–235. doi: 10.1093/rheumatology/14.4.231. [DOI] [PubMed] [Google Scholar]
- OLHAGEN B. POLYMYALGIA RHEUMATICA. A FORM OF SENILE ARTERITIS? Acta Rheumatol Scand. 1963;9:157–164. [PubMed] [Google Scholar]
- Rynes R. I., Mika P., Bartholomew L. E. Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica. Ann Rheum Dis. 1977 Feb;36(1):88–90. doi: 10.1136/ard.36.1.88. [DOI] [PMC free article] [PubMed] [Google Scholar]